Panel Discussion: Evaluating Changing FDA & GMP Expectations to Overcome Regulatory Challenges & Accelerate Clinical Approval

2:30 pm - Wednesday 25th March 2026

  • Understand how Treg GMP and approval processes have evolved for 2026
  • Sharing FDA interactions to reveal and combat manufacturing and regulatory approval challenges
  • Identifying opportunities for accelerated regulatory progression amid regulatory changes

Speakers:

Professor of Microbiology-Immunology
Northwestern University
General Manager
Singulera Therapeutics
Founder & Chief Executive Officer
TregShield Bio